Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Abstract Prostate cancer is one of the most diagnosed cancers among men worldwide. Prolactin is a pituitary hormone that can influence androgen regulation, and antipsychotics that increase prolactin may suppress testosterone levels. Because lower free testosterone has been associated with lower prostate cancer risk, prolactin-increasing antipsychotics may have a potential protective effect. However, this association has not been well characterized in real-world comparative studies.
Topiramate use was linked to a significantly higher glaucoma risk than valproate or lamotrigine, especially early after initiation. Elevated risk was concentrated in women and epilepsy patients; no significant increase was seen in men or migraine patients. Higher topiramate doses, more common in epilepsy, may partly explain the elevated glaucoma risk observed. Sex- and indication-specific risk stratification may guide safer ASM selection and targeted ophthalmologic monitoring.
ORIGINAL ARTICLE Yongfeng Chen MSN, RN, Corresponding Author Yongfeng Chen MSN, RN 402860772@qq.com orcid.org/0000-0001-5925-8629 Vice-director of the Nursing Department, Guangxi Academy of Medical Sciences, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China Correspondence Yongfeng Chen, Guangxi Academy of Medical Sciences, The People’s Hospital of Guangxi Zhuang Autonomous Region, 6 Taoyuan road, Nanning, 530021, China.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
